<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"
>
<channel>
<title>WSJ.com: Health</title>
<description>The latest news on health and wellness, including the healthcare industry, pharmaceuticals and more</description>
<link>https://www.wsj.com/health</link>
<language>en-us</language>
<copyright>Copyright &#169; Dow Jones &amp; Company, Inc. All rights reserved.</copyright>
<lastBuildDate>Tue, 07 Jul 2026 17:59:34 GMT</lastBuildDate>
<image>
<title>WSJ.com: Health</title>
<url>http://www.wsj.com/img/wsj_sm_logo.gif</url>
<link>https://www.wsj.com/health</link>
</image>
<item>
<guid isPermaLink="false">WP-WSJ-0003714892</guid>
<title>Nestl&#xe9; is looking to spice up some of its products to counter the duller taste buds that can accompany GLP-1 weight-loss drugs</title>
<description>The company is looking to spice up some of its products to counter changes in taste that can accompany weight-loss drugs.</description>
<link>https://www.wsj.com/health/pharma/nestle-to-tweak-some-food-recipes-to-appeal-to-duller-glp-1-palates-e7a22127</link>
<pubDate>Tue, 07 Jul 2026 10:32:00 GMT</pubDate>
<dc:creator>Aimee Look</dc:creator>
<media:content url="https://images.wsj.net/im-56228522" medium="image" type="image/jpeg">
<media:credit>Audra Melton for WSJ</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003711742</guid>
<title>Novartis to Buy Myricx Bio for Up to $1.5 Billion</title>
<description>The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis&#x2019;s oncology capabilities.</description>
<link>https://www.wsj.com/health/pharma/novartis-to-buy-myricx-bio-for-up-to-1-5-billion-6e8ee865</link>
<pubDate>Mon, 06 Jul 2026 08:50:00 GMT</pubDate>
<dc:creator>Aimee Look</dc:creator>
<media:content url="https://images.wsj.net/im-78108016" medium="image" type="image/jpeg">
<media:credit>Mike Blake/Reuters</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003706594</guid>
<title>As dementia complicates caregiving, families confront a painful question: Is deception ever the kinder choice?</title>
<description>Millions of adult children face agonizing decisions when their parents can no longer care for themselves.</description>
<link>https://www.wsj.com/health/wellness/how-far-would-a-daughter-go-to-save-her-aging-parents-from-self-neglect-9170f67a</link>
<pubDate>Sat, 04 Jul 2026 15:04:00 GMT</pubDate>
<dc:creator>Clare Ansberry</dc:creator>
<media:content url="https://images.wsj.net/im-89278499" medium="image" type="image/jpeg">
<media:credit>Getty Images</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003414327</guid>
<title>Dementia directives are gaining popularity among people who&#x2019;ve been diagnosed with dementia or have a high likelihood of it in the future. Here is what to know about them.</title>
<description>A &#x201c;dementia directive&#x201d; can spell out your wishes at various stages of the disease. Even if you don&#x2019;t have dementia, it doesn&#x2019;t hurt to plan.</description>
<link>https://www.wsj.com/health/wellness/dementia-living-will-fefd912c</link>
<pubDate>Fri, 03 Jul 2026 14:00:00 GMT</pubDate>
<dc:creator>Cheryl Winokur Munk</dc:creator>
<media:content url="https://images.wsj.net/im-82618209" medium="image" type="image/jpeg">
<media:credit>Marine Buffard for WSJ</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003707043</guid>
<title>Here&#x2019;s what to know about the latest developments in sunscreen as you head outside for the Fourth of July</title>
<description>Here&#x2019;s what to know about the latest developments heading into the July 4 weekend.</description>
<link>https://www.wsj.com/health/wellness/sunscreen-sun-protection-explained-04cdb81a</link>
<pubDate>Fri, 03 Jul 2026 13:38:00 GMT</pubDate>
<dc:creator>Celia Bernhardt</dc:creator>
<media:content url="https://images.wsj.net/im-76819621" medium="image" type="image/jpeg">
<media:credit>Zack Wittman for WSJ</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003703997</guid>
<title>Heard on the Street: Medicare is now covering weight-loss drugs for some seniors, in a win for patients. For Wall Street, the math is trickier.</title>
<description>Medicare is now covering weight-loss drugs for some seniors, in a win for patients. For Wall Street, the math is trickier.</description>
<link>https://www.wsj.com/health/pharma/why-medicare-isnt-a-game-changer-for-weight-loss-drugmakers-36bdae96</link>
<pubDate>Thu, 02 Jul 2026 09:30:00 GMT</pubDate>
<dc:creator>David Wainer</dc:creator>
<media:content url="https://images.wsj.net/im-37624438" medium="image" type="image/jpeg">
<media:credit>Shelby Knowles/Bloomberg</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003700356</guid>
<title>Zyn can be marketed as safe alternative to cigarettes, FDA says</title>
<description>The federal regulator gave Philip Morris International a win for nicotine pouches.</description>
<link>https://www.wsj.com/health/healthcare/zyn-can-be-marketed-as-safe-alternative-to-cigarettes-fda-says-f22dfb34</link>
<pubDate>Tue, 30 Jun 2026 18:34:00 GMT</pubDate>
<dc:creator>Laura Cooper</dc:creator>
<media:content url="https://images.wsj.net/im-95753941" medium="image" type="image/jpeg">
<media:credit>Michael M. Santiago/Getty Images</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003679714</guid>
<title>More drug companies are taking their clinical trials to China and Australia. U.S. officials are making moves to keep them at home.</title>
<description>FDA and NIH officials unveiled a package of regulatory tweaks as more companies go elsewhere for drug research.</description>
<link>https://www.wsj.com/health/healthcare/u-s-to-speed-up-early-drug-research-to-better-compete-with-china-7b32b7ff</link>
<pubDate>Mon, 22 Jun 2026 18:28:00 GMT</pubDate>
<dc:creator>Liz Essley Whyte</dc:creator>
<dc:creator>Xavier Martinez</dc:creator>
<media:content url="https://images.wsj.net/im-07003904" medium="image" type="image/jpeg">
<media:credit>Sarah Silbiger/Getty Images</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003665565</guid>
<title>Utah is testing out AI doctors for prescription refills and actual doctors aren&#x2019;t happy about it</title>
<description>Utah&#x2019;s pilot program to have artificial-intelligence chatbots refill prescriptions has angered doctors who worry it isn&#x2019;t safe.</description>
<link>https://www.wsj.com/health/healthcare/ai-doctors-utah-374653c8</link>
<pubDate>Thu, 18 Jun 2026 14:41:00 GMT</pubDate>
<dc:creator>Anna Wilde Mathews</dc:creator>
<media:content url="https://images.wsj.net/im-77988541" medium="image" type="image/jpeg">
<media:credit>Daisy Korpics/WSJ, iStock</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003648281</guid>
<title>Johnson &amp; Johnson CEO Says Cure for Certain Cancers Is Realistic Goal</title>
<description>Joaquin Duato said AI was already helping the company develop medicines faster, but the extent to which it boosts its bottom line has yet to be seen.</description>
<link>https://www.wsj.com/health/healthcare/johnson-johnson-ceo-says-cure-for-certain-cancers-is-realistic-goal-234d2767</link>
<pubDate>Tue, 16 Jun 2026 14:54:00 GMT</pubDate>
<dc:creator>Adri&#xe0; Calatayud</dc:creator>
<media:content url="https://images.wsj.net/im-53774722" medium="image" type="image/jpeg">
<media:credit>Heather Diehl/Getty Images</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003649866</guid>
<title>Some of the biggest Medicare insurers had some of the highest rates of denying costly nursing-home care, a new federal investigation shows</title>
<description>A new federal investigation shows some of the biggest insurers had some of the highest denial rates.</description>
<link>https://www.wsj.com/health/healthcare/big-medicare-insurers-often-deny-requests-for-nursing-home-stays-96817df9</link>
<pubDate>Thu, 11 Jun 2026 12:00:00 GMT</pubDate>
<dc:creator>Anna Wilde Mathews</dc:creator>
<media:content url="https://images.wsj.net/im-83665010" medium="image" type="image/jpeg">
<media:credit>Getty Images</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003705259</guid>
<title>Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial</title>
<description>Experimental drug, divarasib, showed meaningful improvements in both patients&#x2019; overall survival and the time they survived without the disease worsening.</description>
<link>https://www.wsj.com/health/pharma/roche-lung-cancer-drug-candidate-beats-existing-therapies-in-late-stage-trial-548e7ca0</link>
<pubDate>Thu, 02 Jul 2026 05:50:00 GMT</pubDate>
<dc:creator>Adri&#xe0; Calatayud</dc:creator>
<media:content url="https://images.wsj.net/im-59262996" medium="image" type="image/jpeg">
<media:credit>Arnd Wiegmann/Reuters</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003699881</guid>
<title>Starting July 1, millions of America&#x2019;s seniors can get weight-loss drug coverage for the first time at an out-of-pocket cost of $50 a month. Here&#x2019;s what to know.</title>
<description>Millions of older Americans are on the cusp of more affordable access to popular weight-loss drugs when a major Medicare coverage expansion kicks in July 1.</description>
<link>https://www.wsj.com/health/pharma/the-latest-senior-citizen-special-is-here-cheap-weight-loss-drugs-6ef60165</link>
<pubDate>Wed, 01 Jul 2026 09:00:00 GMT</pubDate>
<dc:creator>Peter Loftus</dc:creator>
<media:content url="https://images.wsj.net/im-88807993" medium="image" type="image/jpeg">
<media:credit>Hannah Beier/Reuters</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003702243</guid>
<title>Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million</title>
<description>The move marks Ipsen&#x2019;s second acquisition this week after its agreement to take over Kartos Therapeutics, a company developing a drug to treat a rare blood cancer.</description>
<link>https://www.wsj.com/health/pharma/ipsen-to-buy-swiss-biotech-memo-in-deal-that-could-top-800-million-30979c46</link>
<pubDate>Wed, 01 Jul 2026 05:55:00 GMT</pubDate>
<dc:creator>Adri&#xe0; Calatayud</dc:creator>
<media:content url="https://images.wsj.net/im-03557671" medium="image" type="image/jpeg">
<media:credit>abdul saboor/Reuters</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003699262</guid>
<title>Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial</title>
<description>The Danish biotechnology company and partner AbbVie said a drug combination to treat lymphoma met the primary goal in a late-stage clinical trial.</description>
<link>https://www.wsj.com/health/pharma/genmab-shares-climb-after-lymphoma-therapy-hits-goal-in-trial-64ebf887</link>
<pubDate>Tue, 30 Jun 2026 09:35:00 GMT</pubDate>
<dc:creator>Adri&#xe0; Calatayud</dc:creator>
<media:content url="https://images.wsj.net/im-45975285" medium="image" type="image/jpeg">
<media:credit>Joost Melis</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003691727</guid>
<title>European Regulator Calls for Amgen&#x2019;s Tavneos to Have Authorization Revoked</title>
<description>The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.</description>
<link>https://www.wsj.com/health/pharma/european-regulator-calls-for-amgens-tavneos-to-have-authorization-revoked-b3922308</link>
<pubDate>Fri, 26 Jun 2026 14:40:00 GMT</pubDate>
<dc:creator>Dean Seal</dc:creator>
<media:content url="https://images.wsj.net/im-93278723" medium="image" type="image/jpeg">
<media:credit>robert galbraith/Reuters</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003673564</guid>
<title>More than 100 chatbots are marketed specifically for mental health, but experts warn they shouldn&#x2019;t supplant therapy</title>
<description>Over 100 chatbots are marketed as mental-health-focused, but experts warn they shouldn&#x2019;t take the place of therapy.</description>
<link>https://www.wsj.com/health/wellness/chatbots-are-replacing-therapists-with-little-scientific-evidence-behind-them-584a1532</link>
<pubDate>Tue, 30 Jun 2026 00:00:00 GMT</pubDate>
<dc:creator>Alex Janin</dc:creator>
<dc:creator>Andrea Petersen</dc:creator>
<media:content url="https://images.wsj.net/im-71484701" medium="image" type="image/jpeg">
<media:credit>Daisy Korpics/WSJ, Everett Collection</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003690294</guid>
<title>Meditation never worked for me, so I had Harvard researchers scan my brain, writes WSJ columnist Elizabeth Bernstein</title>
<description>Our columnist turned to science to see what happened when she tried to slow her mind.</description>
<link>https://www.wsj.com/health/wellness/meditation-never-worked-for-me-so-i-had-harvard-researchers-scan-my-brain-77180ef7</link>
<pubDate>Sat, 27 Jun 2026 11:00:00 GMT</pubDate>
<dc:creator>Elizabeth Bernstein</dc:creator>
<media:content url="https://images.wsj.net/im-50799290" medium="image" type="image/jpeg">
<media:credit>Sasha Pedro for WSJ</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003504611</guid>
<title>If people ate better, we would have less disease and lower healthcare costs in the U.S. Two longevity experts at USC say bolder action is needed to get that message across.</title>
<description>We need to restructure healthcare, treat food as medicine and embrace eating programs that work in the long term.</description>
<link>https://www.wsj.com/health/wellness/diet-healthcare-solutions-cc445f24</link>
<pubDate>Fri, 26 Jun 2026 19:00:00 GMT</pubDate>
<dc:creator>Sebastian Brandhorst</dc:creator>
<dc:creator>Valter Longo</dc:creator>
<media:content url="https://images.wsj.net/im-71155716" medium="image" type="image/jpeg">
<media:credit>Johnny Simon/WSJ, iStock</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003689895</guid>
<title>The lone-star tick is spreading across America. Plus, the future of Alzheimer&#x2019;s care, young kids on GLP-1s and our columnist&#x2019;s silent retreat, in this week&#x2019;s Health newsletter:</title>
<description>Plus, the future of Alzheimer&#x2019;s care, young kids on GLP-1s and our columnist&#x2019;s silent retreat.</description>
<link>https://www.wsj.com/health/wellness/beware-the-tick-that-causes-a-red-meat-allergy-4de0dd8d</link>
<pubDate>Fri, 26 Jun 2026 16:55:00 GMT</pubDate>
<dc:creator>Leigh Kamping-Carder</dc:creator>
<media:content url="https://images.wsj.net/im-48870256" medium="image" type="image/jpeg">
<media:credit>Lauren Bishop/CDC/Associated Press</media:credit>
</media:content>
</item>
<item>
<guid isPermaLink="false">WP-WSJ-0003665286</guid>
<title>After years of downloading meditation apps and ignoring their notifications, our writer checked into a five-day silent retreat near the Berkshires, Mass.</title>
<description>A silent, no-phones retreat reveals how disorienting it can be when the mind is cut off from constant digital input</description>
<link>https://www.wsj.com/health/wellness/buddhist-silent-retreat-massachusetts-insight-meditation-society-35833979</link>
<pubDate>Tue, 23 Jun 2026 09:30:00 GMT</pubDate>
<dc:creator>Pamela Paul</dc:creator>
<media:content url="https://images.wsj.net/im-53179661" medium="image" type="image/jpeg">
<media:credit>NIKOLAI SENIN FOR WSJ</media:credit>
</media:content>
</item>
</channel>
</rss>